Tak BioSuisse delivers strategic consulting solutions that drive execution and tangible results for biopharma’s market access, pricing, and HEOR functions. We provide expert advisory services across the full product lifecycle - from early development to launch and beyond - empowering companies with actionable insights and robust strategies to optimize market access, pricing, and health outcomes. 

HTA Compass™: Simplifying JCA Submissions
The flagship product, HTA Compass™, is a cutting-edge digital platform designed to streamline the preparation and submission of Joint Clinical Assessment (JCA) dossiers under the EU HTA regulation. By replacing fragmented workflows and outdated tools and processes, HTA Compass™ enables health technology developers to confidently navigate regulatory complexities.

Get in touch with us at sameera@takbiosuisse to discuss advisory services

Book a demo on HTA Compass™ - https://calendly.com/htacompass-takbiosuisse/30min

Tak BioSuisse

Org chart

Teams

Offices